Serious adverse events in African–American cancer patients with sickle cell trait and inherited haemoglobinopathies in a SEER-Medicare claims cohort
Hoag JR, Andemariam B, Wang X, Gregorio DI, Jones BA, Sporn J, Salner AL, Swede H. Serious adverse events in African–American cancer patients with sickle cell trait and inherited haemoglobinopathies in a SEER-Medicare claims cohort. British Journal Of Cancer 2019, 120: 861-863. PMID: 30890774, PMCID: PMC6474269, DOI: 10.1038/s41416-019-0416-7.Peer-Reviewed Original ResearchMeSH KeywordsBlack or African AmericanDrug-Related Side Effects and Adverse ReactionsFemaleHemoglobinopathiesHumansMaleMedicareNeoplasmsPatientsRisk FactorsSEER ProgramSickle Cell TraitUnited StatesWhite PeopleConceptsSickle cell traitAfrican American cancer patientsSerious adverse eventsAdverse eventsNon-Hispanic whitesCancer patientsRelative riskCell traitEmergency department visitsSEER-Medicare databaseDepartment visitsPrognostic impactAA patientsCancer outcomesWorse outcomesProstate cancerCohort analysisPatientsClaims cohortMagnitude of effectCancer typesAA populationHaemoglobinopathiesOutcomesRisk